Leica Microsystems and TrueVision 3D Surgical announced today that Leica will incorporate key components of TrueVision's 3D intelligent digital visualization and guidance platform into selected Leica Microsystems surgical products under the Leica brand. In addition to co-marketing the Leica and 3D by TrueVision products, the two companies will collaborate on advanced projects that will further integrate their respective optical and digital technologies to improve microsurgery outcomes in Ophthalmology and Neurosurgery.
TrueVision is a real-time, stereoscopic, 3D high-definition visualization system for micro-surgery. It will be integrated into Leica Microsystems' surgical microscopes to display the surgical field of view on 3D flat panel dis-plays in the operating room. TrueVision com-bines 3D visualization with guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. It also enables surgeons to record surgery in 3D and to stream live video of the surgical field, making it an unparalleled teaching tool.
Leica Microsystems is presenting the TrueVision® line of products at the annual Congress of Neurological Surgeons in Washington DC, October 1-6, 2011, Booth# 548. It is the debut of a collaboration which is expected to bring integrated 3D visualization and guidance for microsurgery into the main stream as a standard of care.
“We are very pleased to have Leica Microsystems as a worldwide partner,” says Forrest Fleming, CEO of TrueVision 3D Surgical, “As a world leader in surgical microscopes, Leica adds significant distribution and technology resources to our current sales efforts globally, and accelerates commercialization of the TrueVision brand in 3D computer-aided surgery.”
“TrueVision products are a great add-on to our product portfolio,” says Silvio Bracone, Vice President of the Medical Division of Leica Microsystems, “we are very excited to cooperate and drive superior technology in the OR com-bining our almost 40 years of know-how in surgical microscopy with TrueVision's 3D technology.”
The com-prehensive worldwide agreement will have a phased approach for specific product developments over a three year term. Specific details of the agreement are not disclosed.